why choose us

First received: June 09, 2023

Clinical Trial: CAR T-cell Therapy in Patients With Renal Dysfunction

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Non-hodgkin Lymphoma,B Cell

Study Type: INTERVENTIONAL


Official Title: Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy in Patients With Moderate-Severe Renal Dysfunction

Brief Summary: This is a prospective, descriptive study designed to assess the feasibility of administering CAR T therapy among patients with moderate to severe renal impairment using dose adjusted lymphodepleting chemotherapy.

Read more